Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.10.4999

Metabolic Syndrome and Colorectal Cancer: A Cross-Sectional Survey  

Forootan, Mojgan (Gastroenterology and Liver Diseases Research Center, Shaheed Beheshti University of Medical Sciences)
Tabatabaeefar, Morteza (Imam Hossein Hospital, Shaheed Beheshti University of Medical Sciences)
Yahyaei, Mansooreh (Gastroenterology and Liver Diseases Research Center, Shaheed Beheshti University of Medical Sciences)
Maghsoodi, Nakisa (Gastroenterology and Liver Diseases Research Center, Shaheed Beheshti University of Medical Sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.10, 2012 , pp. 4999-5002 More about this Journal
Abstract
Introduction: There is epidemiological evidence indicating that the metabolic syndrome increases the risk of colorectal cancer. Since there is little information about this issue in Iran, the present study was conducted to evaluate prevalence of metabolic syndrome and its components in patients with colorectal cancer. Material and Methods: This cross-sectional survey involved 200 patients with a new diagnosis of colorectal cancer. Demographic information of patients was collected through the interview with them. Components of metabolic syndrome including fasting glucose serum, triglyceride, high density lipoprotein, blood pressure and waist circumference were measured for all of the patients. Results: A total of 72 colorectal cancer patients (36%) met metabolic syndrome criteria with rates of 76% for women and 24% for men. BMI in metabolic syndrome patients was higher than other colorectal cancer patients. Disease history including hypertension, diabetes and cardiovascular disease was most frequent in metabolic syndrome patients. Pathological characteristics of colorectal cancer were not significantly associated with the disease. Conclusion: The findings of present study indicated that the prevalence of metabolic syndrome in CRC patients is relatively high. Therefore, further analytical and multi centric studies are needed to better understand the role of metabolic syndrome in development of CRC in Iran. If this association is confirmed in future studies, metabolic syndrome patients should be considered in CRC screening programs.
Keywords
Colorectal cancer; metabolic syndrome; diabetes; hyperlipidemia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim JH, Lim YJ, Kim YH, et al (2007). Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev, 16, 1543-6.   DOI
2 Morita T, Tabata S, Mineshita M, et al (2005). The metabolic syndrome is associated with increased risk of colorectal adenoma development: the self-defense forces health study. Asian Pac J Cancer Prev, 6, 485-9.
3 Pais R, Silaghi H, Silaghi AC, et al (2009). Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol, 15, 5141-8.   DOI
4 Pelucchi C, Negri E, Talamini R, et al (2010). Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer, 46, 1866-72.   DOI   ScienceOn
5 Rigo JC, Vieira JL, Dalacorte RR, et al (2009). Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods. Arq Bras Cardiol, 93, 85-91.   DOI
6 Safaee A, Fatemi R, Pourhoseingholi M, et al (2009). Positive Association between diabetes mellitus and risk of colorectal cancer. Iran J Cancer Prev, 2, 189-93.
7 Schoen RE, Tangen CM, Kuller LH, et al (1999). Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst, 91, 1147-54.   DOI
8 Siddiqui AA (2011). Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci, 341, 227-31.   DOI
9 Slattery ML, Murtaugh M, Caan B, et al (2004). Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control, 15, 863-72.   DOI
10 Ahmed RL, Schmitz KH, Anderson KE, et al (2006). The metabolic syndrome and risk of incident colorectal cancer. Cancer, 107, 28-36.   DOI
11 Ayatollahi SM, Ghoreshizadeh Z (2010). Prevalence of obesity and overweight among adults in Iran. Obes Rev, 11, 335-7.   DOI
12 Cameron AJ, Shaw JE, Zimmet PZ (2004). The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am, 33, 351-75.   DOI   ScienceOn
13 Chiu HM, Lin JT, Shun CT, et al (2007). Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol, 5, 221-9.   DOI
14 Chung YW, Han DS, Park YK, et al (2006). Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis, 38, 668-72.   DOI   ScienceOn
15 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001). JAMA, ?, PAGE?-?.
16 Frezza EE, Wachtel MS, Chiriva-Internati M (2006). Influence of obesity on the risk of developing colon cancer. Gut, 55, 285-91.   DOI
17 Giovannucci E (2003). Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res, 35, 694-704.   DOI
18 Wang YY, Lin SY, Lai WA, et al (2005). Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepatol, 20, 1410-5.   DOI
19 Sturmer T, Buring JE, Lee IM, et al (2006). Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev, 15, 2391-7.   DOI
20 Tsilidis KK, Brancati FL, Pollak MN, et al (2010). Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control, 21, 1-10.   DOI